Breast Cancer
Article
Key Studies in Metastatic Breast Cancer From ASCO 2020
Key studies in metastatic breast cancer from ASCO 2020 focus on first-line checkpoint inhibition in TNBC; also, updated...
Article
‘A good and peaceful death’: Cancer hospice during the pandemic
News
TILs and PET-CT can predict pCR in HER2-positive metastatic breast cancer
News
Treating primary tumor doesn’t improve OS in stage IV breast cancer
News
Pyrotinib bests lapatinib in HER2+ metastatic breast cancer
Patients who received pyrotinib had longer progression-free survival but a higher rate of grade 3 diarrhea.
News
Expanding the role of PARP inhibitors in breast cancer
News
Tucatinib improves PFS, OS in HER2+ breast cancer with brain metastases
News
Pembrolizumab plus chemo shows benefits for PD-L1–rich triple-negative breast cancer
Patients with triple-negative breast cancers with PD-L1 combined positive score higher than 10 had better progression-free survival with...
News
LOTUS: Ipatasertib plus paclitaxel may prolong OS in TNBC
Ipatasertib provided a “clinically meaningful,” but not statistically significant, 9-month improvement in median overall survival.
News
Mammography cuts risk for fatal breast cancers: New data
A large study showed a survival benefit from mammography, but an expert questioned the study’s methodology.